|
Citation
|
Knowles LM, Esselman EC, Turner AP, Phillips KM, Herring TE, Alschuler KN, Ehde DM. Arch. Phys. Med. Rehabil. 2020; ePub(ePub): ePub. |
|
Abstract
|
OBJECTIVES: To (1) describe depressive symptom severity and suicidal ideation (SI) in persons with progressive multiple sclerosis (MS); (2) compare depressive symptom severity and SI in persons with progressive MS and persons with relapsing-remitting MS (RRMS); and (3) identify common and unique risk factors for greater depressive symptom severity and SI in persons with progressive MS compared to individuals with RRMS.
DESIGN: Observational, cross-sectional survey study.
SETTING: Community PARTICIPANTS: 573 adults with MS.
INTERVENTIONS: Not applicable.
MAIN OUTCOME MEASURE(S): The dependent variables were depression symptoms and any SI measured by the Patient Health Questionnaire-9. Comparisons between groups used t-test and chi-square analyses, and risk factors were tested by examining the interaction of MS subtype (progressive MS and RRMS) and each risk factor in multiple regression models with bootstrapping.
RESULTS: Persons with progressive MS did not differ from persons with RRMS in levels of depressive symptoms or SI. Both groups reported mild depressive symptoms and approximately 10% endorsed SI. Common risk factors for greater depressive symptom severity were younger age, greater disability, greater speech and swallowing problems, and lower household income. Common risk factors for SI were shorter disease duration, greater disability, and greater speech and swallowing problems.
CONCLUSIONS: In this sample, there were no group differences between persons with progressive MS and persons with RRMS in depressive symptom severity and SI. Although both groups reported mild depressive symptoms on average, nearly one in four persons met criteria for probable major depression, which underscores the importance of screening for and treating depressive disorders in all persons with MS.
Language: en |